Home » Newsletters » BioWorld Science

BioWorld Science

April 30, 2004

View Archived Issues

Further data on efficacy of solifenacin for overactive bladder therapy

INO-1001 ameliorates ischemia/reperfusion injury in a canine heart transplant model

FK-778 reduces expression of adhesion molecules in preclinical models of allograft rejection

Novartis presents new S1P agonists with immunomodulating properties

Novel p38 inhibitors identified at Boehringer Ingelheim

AACAP guidelines recommend Strattera as first-line therapy for ADHD

Cubane-based mGluR modulators with activity in stroke and anxiety models

Novartis claims new substance P antagonists and their use

Novel protein kinase inhibitors in early development at Aventis

Novel TGF-beta inhibitors identified by Scios researchers

New PPARalpha/PPARgamma agonists prepared and tested at Roche

European Commission approved Sanofi-Synthelabo/Aventis tie-up

First two phase III trials for ferumoxytol commence

Mycamine NDA submitted for esophageal candidiasis

R&D highlights from the 3rd Annual Global Biotech Forum for Investing & Partnering: Zelos

R&D highlights from the 3rd Annual Global Biotech Forum for Investing & Partnering: Therion

Curcumin effective against human retinal endothelial cell proliferation

Second stage entered in phase I study of SPL-7013

Esteve takes marketing rights to Wilex's Rencarex in Southern Europe

Zimmer Holdings completes acquisition of Implex

European approval for Velcade in multiple myeloma

Praecis and Schering AG enter Plenaxis commercialization agreement

German approval for Niaspan

Elan completes sale of Zonegran to Eisai

Bristol-Myers Squibb and Merck & Co enter global alliance for muraglitazar

Positive data for HuMax-CD4 in phase II CTCL studies

Chugai and Roche enter second research collaboration

M-40403 improves analgesic profile of morphine in phase II trial

Natalizumab reported safe and effective in pediatric multiple sclerosis

Therapeutic benefits of ruboxistaurin mesilate in patients with DPN

Adjunctive therapy with lerdelimumab after phacotrabeculectomy beneficial for IOP

Vaccines suggested as an alternative for treating glaucoma

Involvement of COX-2 and MMP-9 in nitric oxide-mediated inflammation in animal model of migraine

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...